{"id":"W4402704907","doi":"10.1016/j.annonc.2024.08.1685","title":"1604P PSMA-targeted radioligand therapy (RLT) with 131I-LNTH-1095 (1095) plus enzalutamide (enza) vs enza alone in chemotherapy-naïve patients (pts) whose piflufolastat F 18-avid metastatic castration-resistant prostate cancer (mCRPC) progressed on abiraterone (abi): ARROW","year":2024,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; London Health Sciences Centre; Princess Margaret Cancer Centre; Université Laval","funders":"","keywords":"Enzalutamide; Medicine; Prostate cancer; Oncology; Radioligand; Internal medicine; Chemotherapy; Urology; Androgen receptor; Cancer; Receptor","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003756072,0.0003547235,0.0007130085,0.0002279613,0.0001691688,0.0004070478,0.0003932744,0.0004588764,0.004409879],"category_scores_gemma":[0.0004517234,0.0001617735,0.0004748982,0.0002365931,0.0004541542,0.0005915753,0.0001779586,0.000954467,0.0003625768],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004817691,"about_ca_system_score_gemma":0.0006956347,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003204036,"about_ca_topic_score_gemma":0.007176746,"domain_scores_codex":[0.9998634,0.00004584208,0.000009109967,0.00001933431,0.00001075874,0.00005162448],"domain_scores_gemma":[0.9998241,0.00004657828,0.00001994076,0.00001093745,0.000004959988,0.0000934982],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.7985814,0.01272518,0.006087866,0.000425288,0.0008419538,0.0004915942,0.0002129388,0.004917858,0.04831772,0.0008785672,0.00478919,0.1217305],"study_design_scores_gemma":[0.1712165,0.723191,0.0646906,0.0001147146,0.001823985,0.0009956177,0.0003702276,0.007806288,0.01953109,0.000945918,0.009225403,0.00008869478],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9954306,0.001186144,0.0001041399,0.0002404651,0.0001359512,0.00007503806,0.000255398,0.00003247523,0.002539769],"genre_scores_gemma":[0.9974853,0.0005460753,0.0001784408,0.00009759007,0.00003981724,0.00003417429,0.0002661967,0.000003885055,0.001348603],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004409879,"threshold_uncertainty_score":0.01475251,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07466563848155026,"score_gpt":0.3938245005664609,"score_spread":0.3191588620849106,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}